Candidate's Plans/Training: The candidate plans a career as an independent clinical investigator focusing on patient-oriented research related to pulmonary vascular disease. Training will include formal epidemiological course work in clinical research and closely mentored completion of the research protocol. Environment: The Center for Clinical Epidemiology and Biostatistics (CCEB) will provide formal coursework and structured mentoring. The CCEB, Pulmonary Vascular Disease Program, and General Clinical Research Center at the University of Pennsylvania Medical Center will provide research support. Research: Primary pulmonary hypertension (idiopathic) and secondary pulmonary hypertension (associated with portal hypertension, anorectic use, HIV, scleroderma, and other collagen vascular diseases) cause substantial morbidity and mortality. Although there are available therapies and interventions, they may be costly and risky in themselves. In addition, targeting therapy at the mechanism of morbidity and mortality and distinguishing highrisk patients have been suboptimal. There is evidence that certain vasoactive substances may play an important role in the disease process of pulmonary arterial hypertension. Studies have documented elevated levels of endothelin, natriuretic peptides, and norepinephine in patients with this disease. It is well known that these neurohormones play important mechanistic and predictive roles in left-sided heart failure. Similarly, there is much potential for these neurohormone levels in determining 1) the mechanism of disease and 2) the prognosis in pulmonary arterial hypertension. We propose an investigation of patients with pulmonary arterial hypertension to examine whether levels of these biomarkers at baseline and at six month follow-up are associated with right-sided heart failure and cardiovascular death. We will formulate prediction rules using neurohormone levels and clinical variables to improve prognostication and management in this disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Mentored Patient-Oriented Research Career Development Award (K23)
Project #
7K23HL067771-02
Application #
6553167
Study Section
Special Emphasis Panel (ZHL1-CSR-F (M1))
Program Officer
Wilde, David B
Project Start
2001-09-01
Project End
2006-08-31
Budget Start
2001-11-01
Budget End
2002-08-31
Support Year
2
Fiscal Year
2001
Total Cost
$130,180
Indirect Cost
Name
Columbia University (N.Y.)
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Al-Naamani, Nadine; Palevsky, Harold I; Lederer, David J et al. (2016) Prognostic Significance of Biomarkers in Pulmonary Arterial Hypertension. Ann Am Thorac Soc 13:25-30
Fang, Adam; Studer, Sean; Kawut, Steven M et al. (2011) Elevated pulmonary artery pressure is a risk factor for primary graft dysfunction following lung transplantation for idiopathic pulmonary fibrosis. Chest 139:782-787
Roberts, Kari E; Kawut, Steven M; Krowka, Michael J et al. (2010) Genetic risk factors for hepatopulmonary syndrome in patients with advanced liver disease. Gastroenterology 139:130-9.e24
Christie, Jason D; Bellamy, Scarlett; Ware, Lorraine B et al. (2010) Construct validity of the definition of primary graft dysfunction after lung transplantation. J Heart Lung Transplant 29:1231-9
Hoffman, S A; Wang, L; Shah, C V et al. (2009) Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation. Am J Transplant 9:389-96
Kawut, Steven M; Al-Naamani, Nadine; Agerstrand, Cara et al. (2009) Determinants of right ventricular ejection fraction in pulmonary arterial hypertension. Chest 135:752-759
Peng, Tien; Zamanian, Roham; Krowka, Michael J et al. (2009) Plasma levels of S100A4 in portopulmonary hypertension. Biomarkers 14:156-60
Roberts, Kari E; Fallon, Michael B; Krowka, Michael J et al. (2009) Serotonin transporter polymorphisms in patients with portopulmonary hypertension. Chest 135:1470-1475
Kawut, Steven M; Okun, Jeffrey; Shimbo, Daichi et al. (2009) Soluble p-selectin and the risk of primary graft dysfunction after lung transplantation. Chest 136:237-244
Rybak, Debbie; Fallon, Michael B; Krowka, Michael J et al. (2008) Risk factors and impact of chronic obstructive pulmonary disease in candidates for liver transplantation. Liver Transpl 14:1357-65

Showing the most recent 10 out of 34 publications